Explore more topics
SEC reporting owner

ROCHE FINANCE LTD SEC insider disclosures

Explore ROCHE FINANCE LTD's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-14T07:26:40.310Z

Reporting owner CIK
0001053942
Issuers
8
Coverage
verified
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Show the table · 8 rows, 5 columns

Scroll sideways to compare all columns. Select a heading to sort.

Foundation Medicine, Inc.0001488613FMINoYes
Senseonics Holdings, Inc.0001616543SENSNoNo
AILERON THERAPEUTICS INC0001420565ALRNNoNo
Allakos Inc.0001564824ALLKNoNo
Pandion Therapeutics, Inc.0001807901PANDNoNo
Jasper Therapeutics, Inc.0001788028JSPRNoNo
Entrada Therapeutics, Inc.0001689375TRDANoNo
Aligos Therapeutics, Inc.0001799448ALGSNoNo
Foundation Medicine, Inc. ↗Senseonics Holdings, Inc. ↗AILERON THERAPEUTICS INC ↗Allakos Inc. ↗Pandion Therapeutics, Inc. ↗Jasper Therapeutics, Inc. ↗Entrada Therapeutics, Inc. ↗Aligos Therapeutics, Inc. ↗

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Show the table · 0 rows, 6 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.